Tuesday, April 23, 2019 8:26:25 AM
IMO, much of what we crave, the corporate spokesman with a vision, the TV commercials, customer testimonials etc are all coming, but a blitz now would be too early. Customers don’t have a place to go. It’s like the Black Friday ad for a $50 80 inch 4K TV and everyone sleeps in front of the store all night to find they only had ONE.
CELZ is just getting off the ground. The PPS blows...... I know it, you know it, the company knows it.
The OTC is unpredictable. Just the buzz with all of this could have us at .10, or it can fall on deaf ears and put us where we are, sub penny. You know as well as I do that some shit azz stocks run into the quarters on almost nothing. Why not CELZ? I have no clue.
What I do feel strongly about is that they have been down this road before and know what they are doing. How the market reacts is largely out of their control, but when the proper infrastructure is done (trial paper, enough locations, enough trainers, hurdles jumped in Russia etc) the gloves will come off.
IMO, the science is there, the efficacy is there, the demand is there, and with the opioid crisis if full swing, anything that is a proven treatment that is NOT a drug is in the right spot at the right time.
Back in July I felt we would settle .04+ and keep moving, but we lost the momo when the offices did not open in time and CaverStem 2.0 needle was introduced... the OTC flippers and dilution killed the PPS, but many are now reloaded for the real run. I would call it a false start.
My current thoughts.... bail out and run for the hills if you think it’s a scam or mismanaged. Or add and these ridiculous prices and wait for the infrastructure to be in place and for the gloves to come off. CELZ has many adversaries, and they know it and are prepared for it. But hey, that is just me. To each their own.
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM